DETAILED ACTION
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Per amendment dated 8/14/26, claims 1, 3-15 are currently pending in the application, with claims 13-15 being withdrawn from consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected invention, there being no allowable generic or linking claim.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claim 3 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite because it is incomplete as it depends on canceled claim 2.
For the purpose of examination, Examiner interprets claim 3 as being dependent on claim 1.
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Claims 1, 3, 7-10 and 12 are rejected under 35 U.S.C. 103 as being unpatentable over Miyakawa et al. (US 2007/0237922 A1).
Regarding claims 1, 3, 7-10 and 12, Miyakawa teaches extrusion molded articles having a body portion comprising a hollow sealing portion (11) and a body portion comprising a covering layer (3) (Ab.).
Disclosed covering layer (3) comprises, per 100 parts by wt. of the composition (a) 30 to 85 wt. % of rubber, e.g., ethylene-propylene copolymer rubber (reads on b.) and ethylene-propylene-non-conjugated diene copolymer rubber (EPDM), (b) 15 to 70 wt. % of at least one hydrogenated polymer e.g., styrene-ethylene-ethylene-propylene-styrene copolymer (SEEPS, reads on a.), (c) 20 to 63 parts by weight of (c) a crystalline olefin resin, e.g., polypropylene (reads on d.). Likewise, disclosed thermoplastic elastomer composition for the hollow sealing part (11) preferably comprises components, per 100 parts by weight of a composition (a) 30 to 85 wt. %, (b) 15 to 70. wt %, and 4 to 22 parts by weight of (c). Additionally, SEEPS is most preferred (b) from the standpoint of imparting softness and reduced oil bleeding [0017]-[0055].
Disclosed Examples Ex. 1-10 comprise (a) EPDM, (b) SEEPS (Septon ™ 4077, styrene content 30%) and (c) polypropylene (Tables 1 and 2, [0101]). Absent a clear teaching on the % as mol%, Examiner interprets the % to be wt.%.
Miyakawa is silent on a thermoplastic elastomer composition comprising claimed components in one single embodiment as claimed.
At the outset, it is noted that in the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976). See MPEP § 2144.05.
Given the teaching in Miyakawa on ethylene-propylene copolymer rubber and EPDM rubber as being equally suitable for use as component (a), it would have been obvious to one of ordinary skill in the art, as of the effective filing date of the claimed invention, to prepare a compositions of inventive Examples in Tables 1 and 2 by substituting EPDM rubber with ethylene-propylene copolymer rubber, based on their art recognized equivalence, absent evidence to the contrary. Noting that component c. in claim 1 is optional, such a substitution would obviate compositions of instant claims 1, 3, 7-10 and 12. It is noted that the recitations “less than 10 wt.%” (claim 9) and “less than 7 wt.%” (claim 10) for the further thermoplastic polymer include 0 as the lower limit, i.e., the further component is optional.
It is prima facie obvious to substitute equivalents known for the same purpose, so long as the equivalency is recognized in the prior art. In re Ruff, 256 F.2d 590, 118 USPQ 340 (CCPA 1958). An express suggestion to substitute one equivalent component or process for another is not necessary to render such substitution obvious. In re Fout, 675 F.2d 297, 213 USPQ 532 (CCPA 1982). See MPEP 2144.06.
Claims 1, 3-7, 9-11 are rejected under 35 U.S.C. 103 as being unpatentable over Muslet (US 2021/0386904 A1), as evidenced by https://www.exxonmobilchemical.com/en/chemicals/webapi/dps/v1/datasheets/150000000364/0/en .
Regarding claims 1, 3-6, 9-11. Muslet teaches thermoplastic multilayer films comprising a core layer comprising one or more styrenic block copolymers and/or olefinic block (propylene rich) copolymers about 50-about 99 %. Disclosed genus of disclosed styrenic block copolymers includes styrene-ethylene-ethylene-propylene-styrene copolymer (SEEPS, reads on a.) and the genus of propylene-rich copolymers include Vistamaxx 6102 (reads on b.). The core layer may comprise polystyrene in an amount of about 1% to 30% (reads on d.) (Ab.. [0025]-[0028]). Absent a clear teaching on the % as mol%, Examiner interprets the % to be wt.%.
It is noted that Examples in the instant disclosure include Vistamaxx® 6102 and per evidence link, the Vistamaxx 6102 comprises 16 wt.% ethylene content and has a melt index (190oC, 2.16 kg) of 1.4 g/10min.
In the disclosed A/B/A multilayer films, the B layer in Examples 7 and 8 in TABLE 1 comprises SIS, SEEPS and VISTAMAXX®.
Muslet is silent on a thermoplastic elastomer composition comprising claimed components in one single embodiment as claimed.
As stated in the 8 above, in the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists.
Given the teaching in Muslet that the core layer may include one or more styrenic block copolymers and olefinic block (propylene rich) copolymers, and polystyrene (about 1 to 30 mol%), and the teaching on suitable styrenic copolymer and olefinic copolymer species, it would have been obvious to one of ordinary skill in the art, as of the effective filing date of the claimed invention, to prepare a core layer from a composition comprising SEEPS, Vistamaxx 6102 and polystyrene (1-30%).
It is noted that component c. (plasticizer) in claim 1 is optional, and the recitations “less than 10 wt.%” (claim 9) and “less than 7 wt.%” (claim 10) as the further thermoplastic polymer include 0 as the lower limit, i.e., the claimed further thermoplastic polymer is optional. Additionally, with regard to claim 11, polypropylene is not a required component in Muslet’s core layer.
Regarding claim 7, Muslet’s core layer may include styrenic block copolymers (e.g., SEEPS) and olefinic (propylene rich) copolymer (Vistamaxx 6102) at about 50 to about 99 %, and polystyrene (1%) for forming the core layer. Since the styrenic and olefinic copolymers are taught to be equally suitable, it would have would have been prima facie obvious to combine SEEPS and Vistamaxx 6102 in suitable amounts to provide for optimal core film properties, including in an amount as claimed, absent evidence of criticality for the claimed range.
Response to Arguments
In view of the amendment dated 8/14/26, the rejections of record are withdrawn.
Applicant’s arguments with respect to previously presented rejections and applied art have been considered but are moot because the new grounds of rejection do not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument.
With regarding the asserted unexpected results in general, it is noted that the data in Table 1 of the disclosure is limited and relies on the layer B (middle layer) comprising POE2 (Vistamaxx 6012) and PM3 comprising SEEPS and PS, and POE2 (Example 3), and layer B (middle layer) comprising POE2 (Vistamaxx 6012) and PM3 comprising SEEPS and PP, and POE2 (Example 4), said components being present in specific relative amounts and not reasonably commensurate in scope with the claim language.
Conclusion
Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the
examiner should be directed to Satya Sastri at (571) 272 1112. The examiner can be reached Monday-Friday, 9AM-5.30PM (EST). If attempts to reach the examiner by telephone are unsuccessful, the examiner's supervisor, Mr. Robert Jones can be reached at (571)-270-7733. The fax phone number for the organization where this application or proceeding is assigned is (571) 273 8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see https://ppair-my.uspto.gov/pair/PrivatePair. Should you have questions on access to
the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/Satya B Sastri/
Primary Examiner, Art Unit 1762